17 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
been AI-engineered to have increased potency, breadth and resistance to viral escape.
◦The development of VIR-7229 has been supported in whole
8-K
EX-99.1
VIR
Vir Biotechnology Inc
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
2020, and how this mutation might evade immunity.
In February:
medRxiv posted a pre-print manuscript, “SARS-CoV-2 B.1.1.7 escape from mRNA vaccine … that maximize breadth and resistance to viral escape” (Starr, et al.), which highlighted the importance of mAbs that target the RBD, given their high
8-K
EX-99.1
VIR
Vir Biotechnology Inc
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
.
In February:
medRxiv published “SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies” (Collier, et al.), which highlights
8-K
EX-99.2
mlxh64f20nctlj7nz
28 Jan 21
Other Events
4:05pm
8-K
EX-99.1
n7v50p xw2xrnp
10 Nov 20
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
h4v9ys6irymv rqx
16 Sep 20
Other Events
4:07pm
8-K
EX-99.1
y4qs36d 6sp3q8hexr6h
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
424B4
f9ab9f hl
8 Jul 20
Prospectus supplement with pricing info
4:35pm
8-K
EX-99.1
xqx0kni84da1r1g
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
e1jk7yeo8eub
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
4zil fhew7mi
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
fmqbqqbn
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
10-K
yh5mnleet5a19
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
4od7l
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
- Prev
- 1
- Next